NCT06577259View on ClinicalTrials.gov

Study to Assess Relative Bioavailability of BMS-986435 Formulations in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

February 19, 2025

Study Completion Date

February 19, 2025

Conditions
Healthy Participants
Interventions
DRUG

BMS-986435

Specified dose on specified days

Trial Locations (1)

78209

Local Institution - 0001, San Antonio

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06577259 - Study to Assess Relative Bioavailability of BMS-986435 Formulations in Healthy Adult Participants | Biotech Hunter | Biotech Hunter